Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer September 25, 2017December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves First CAR T Cell Immunotherapy for Leukemia August 30, 2017December 14, 2022 Arthur N. Brodsky, PhD
Nivolumab Approved for Patients with Chemotherapy-Resistant, Metastatic, MSI-H Colorectal Cancer August 1, 2017December 14, 2022 Arthur N. Brodsky, PhD
Immunotherapy Makes History with Latest Cancer Approval May 23, 2017December 14, 2022 Arthur N. Brodsky, PhD
FDA approves Keytruda combo for first-line lung cancer treatment May 12, 2017December 14, 2022 Arthur N. Brodsky, PhD
Durvalumab Becomes Newest Immunotherapy Approved for Advanced Bladder Cancer May 5, 2017December 14, 2022 Arthur N. Brodsky, PhD